Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

Generic Pharmaceuticals Market Expected to Grow to USD 942.69 Billion by 2033 | - openPR.com

23 Feb, 2026

Corcept Experiences Legal Setback in Korlym Patent Case - The Globe and Mail

20 Feb, 2026

Corcept Issues Update Regarding Patent Litigation with Teva Pharmaceuticals – Company Statement

19 Feb, 2026

Corcept Offers Update on Legal Battle with Teva Pharmaceuticals - Business Wire

19 Feb, 2026

See More